Key result
Tuberculous pericarditis evidence highlights ongoing gaps in diagnostics, adjunctive steroid efficacy, and HIV-associated outcomes.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Evidence gaps leave tuberculous pericarditis management uncertain; leaves open diagnostic advances, steroid utility, and HIV effects.
Research is needed to improve the diagnosis, assess the effectiveness of adjunctive steroids, and determine the impact of HIV infection on the outcome of tuberculous pericarditis.
No takes yet. Share an insight, caveat, or question.
Mayosi et al. (2005) studied this question. Tuberculous pericarditis requires further research to improve diagnosis, evaluate adjunctive steroids, and determine the impact of HIV infection on clinical outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: